HEALTHDAILY MAIL US
The 'remarkable' link between Mounjaro and pancreatic cancer revealed: It kills three-quarters of patients within a year and cases are rising... but now landmark study shows impact of fat jabs against disease
The article highlights a link between the drug Mounjaro and pancreatic cancer, noting that three-quarters of patients die within a year as cases rise. It also mentions a landmark study examining the impact of 'fat jabs' against the disease.
Related Signal
Adjacent reporting
- The remarkable link between Mounjaro and pancreatic cancer revealed: It kills three-quarters of patients within a year and cases are rising... now landmark study shows impact of fat jabs on disease
- Drug nearly doubles survival rate for some pancreatic cancer patients, study finds
- New pill 'doubles survival time' for pancreatic cancer patients
- New drug nearly doubles survival rates in some pancreatic cancer patients, study says
- WATCH: How a new drug could lengthen lives of pancreatic cancer patients
- Breakthrough pancreatic cancer drug shows survival gains that surprise experts